ftInvstr
INDIACEM · Basic Materials ₹340.5 -1.79% Mkt Cap ₹15879 Cr

INDIACEM

Basic Materials Building Materials
₹340.5
-1.79% today · 30d +14.65%
as of 2026-11-09
Price · Daily Candles
“India Cements: Profitability Rises on OPM Surge, but Growth Remains Elusive.”
Despite a Q1 FY27 net profit of ₹27 Cr and an operating profit margin increase of 6.63% YoY, India Cements faces long-term revenue contraction with a 5-year CAGR of -0.11%. The TTM PE of 133.16 suggests a stretched valuation compared to historical performance.
BULL CASE
+Q1 FY27 net profit stood at ₹27 Cr with operating profit growing 72.45% YoY.
+Operating profit margin (OPM) improved by 6.63% YoY to 15.56% in Q1 FY27.
+ML predictions for Free Cash Flow (FCF) show a strong rank of 0.822 over a stable 7-year horizon.
+The stock is identified by two strategies: Margin_Surge and High Promoter Stake + Profit Growth.
BEAR CASE
−Annual revenue has contracted by 8.4% (3-year CAGR) and 0.11% (5-year CAGR) as of March 2026.
−The TTM PE ratio of 133.16 is significantly higher than most sector peers like UltraTech Cement (41.5) and Ambuja Cements (20.87).
−Current FCF is negative at -₹249 Cr, resulting in a -1.37% FCF yield, making intrinsic value computation challenging.
−DII and FII shareholding decreased by 0.3% and 0.08% respectively QoQ, as of June 2026.
⟳ What Changed
₹ Latest Earnings · Q ending 2026-09-30
REVENUE
₹1142 Cr
+2.24% YoY
NET PROFIT
₹39 Cr
+340.64% YoY
OPM
12.92%
+3.31pp YoY
EPS
₹1.25
PE 133.16
Intrinsic value · DCF: N/A — Company is currently free-cash-flow negative (-1.6% of mktcap). DCF assumes a going concern generating positive cash flow; a meaningful intrinsic value can only be computed once FCF turns positive. Use the Strategy Fit and ML sections instead.
◇ Sector Position
India Cements trades at a TTM PE of 133.16 and has a ROCE of 2.0%, significantly higher PE and lower ROCE compared to peers like UltraTech Cement (PE 41.5, ROCE 13.03%) and Ambuja Cements (PE 20.87, ROCE 9.27%).
PEERPEROCE %
INDIACEM133.162.0
ULTRACEMCO41.513.03
GRASIM21.168.31
AMBUJACEM20.879.27
+ 2 more peers — sign in to view
ML Forward Growth Predictions 🔒

9 ML-predicted forward-growth ranks across sales, EBIT, and FCF.

Sign up freeSign in
43
SCORE / 100
Overall
6-axis composite of the sections below.
Performance UNDERPERFORMER 20
Valuation STRETCHED 5
Growth STEADY 56
Profitability AVERAGE 42
Technicals NEUTRAL 57
Risk LOW 80
Key Stats
TTM PE
133.16
P/B
1.22
52W HIGH
₹485.8
OFF HIGH
-29.91%
MKT CAP
₹15879 Cr
◉ Active Signals
MACDBullish5.2045
RSI(14)Neutral57.73
Street Consensus
4 analysts
₹440.0
mean target
Low ₹350.0Now ₹340.5High ₹600.0
⧉ Strategy Fit 🔒

See which of ftInvstr's 50+ strategies hold INDIACEM and at what entry.

Sign up freeSign in